Last reviewed · How we verify
NCT05809076: GAMMAtACS
Effects of Gamma-tACS on EEG Periodic Activity
NA trial testing real tACS in Transcranial Alternating Current Stimulation in 34 participants. Completed in 18 January 2023.
18 January 2023
Quick facts
| Lead sponsor | IRCCS San Camillo, Venezia, Italy |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 34 |
| Start date | 20 July 2021 |
| Primary completion | 18 January 2023 |
| Estimated completion | 18 January 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- real tACS
- sham tACS
Conditions studied
- Transcranial Alternating Current Stimulation — all drugs for Transcranial Alternating Current Stimulation →
Sponsor
IRCCS San Camillo, Venezia, Italy
Who can join
18 and older, any sex, with Transcranial Alternating Current Stimulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study on healthy subjects, the effect of transcranial alternating current stimulation (tACS) will be investigated. In particular, the distinction between periodic and aperiodic electroencephalogram (EEG) activity will be considered, as well as the state-dependency phenomenon. Participants will take part in two experimental sessions that will include tACS stimulation (one real, one control). Before, during, and after stimulation, subjects will have their EEG recorded during rest or during tasks. The aim of this study is to investigate how the modulatory effects of gamma-tACS interact with intrinsic neural activity, measured in terms of periodic and aperiodic activity, as well as neurophysiological and behavioral modulation, taking into consideration the state-dependency phenomenon, which refers to the brain's activation state prior to stimulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05809076
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of real tACS
Trials testing the same drug.
- NCT07097051 — Multi-session Transcranial Alternating Current Stimulation to Improve Dual-task Standing and Brain Activity in Older Adu · Phase 2 · recruiting
- NCT07347327 — The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke · NA · completed
- NCT05830617 — Modulation of Cortical Gamma Synchrony in Stroke · NA · unknown
Other recruiting trials for Transcranial Alternating Current Stimulation
Currently open trials in the same condition.
- NCT07087873 — Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiop · NA · recruiting
- NCT06874374 — Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder · NA · active not recruiting
- NCT06888726 — Efficacy of Hi-tACS for Schizophrenia Negative Symptoms · NA · recruiting
- NCT06565143 — Effect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease · NA · recruiting
Other IRCCS San Camillo, Venezia, Italy trials
Trials by the same sponsor.
- NCT05956132 — Clinical and Biochemical Features for the Identification of Dominant Calpainopathies · unknown
- NCT05934188 — Exploring the Gut-Brain Axis in Ageing and Neurodegeneration · recruiting
- NCT06264037 — The Experience in Neurorehabilitation Setting: a Qualitative Study · unknown
- NCT06270420 — Technological Devices and Home Automation System in Neurological Rehabilitation · NA · unknown
- NCT05591040 — Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05809076 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS San Camillo, Venezia, Italy
- Last refreshed: 12 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05809076.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing